retatrutide investigational drug triple hormone receptor agonist First-in-Class 'Triple-G'! Retatrutide, a first-in-class GIP, GLP-1 & Glucagon leads to nearly 29% weight loss in first pivotal test! Eli Lilly announced positive topline results from the Retatrutide: A Triple Agonist Shaping
Pay in 4 interest-free payments of $6.87 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Oct 24 - Oct 29



:max_bytes(150000):strip_icc()/VWH-GettyImages-1305341722-b089448f8dc343378c30884a2128b5b9.jpg)














